Fig. 1From: Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patientsImpact of treatment delay on the efficacy of immunotherapy in head and neck cancer patients. CR complete response, PR partial response, PD progressive disease, SD stable diseaseBack to article page